Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries

Fig. 2

QALY value for the different health states. Respondents considered living with schizophrenia/bipolar disorder and having one yearly agitation episode treated with inhaler better than living with the same conditions and receiving treatment with tablets or injection. The utility value was 0.762 for inhalable treatment, 0.707 for injection and 0.734 for tablet treatment. QALY: Quality-adjusted life years

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us